Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-073328
Filing Date
2023-06-21
Accepted
2023-06-21 16:06:22
Documents
5
Effectiveness Date
2023-06-21

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2319079d1_s8.htm S-8 57818
2 EXHIBIT 5.1 tm2319079d1_ex5-1.htm EX-5.1 8327
3 EXHIBIT 23.1 tm2319079d1_ex23-1.htm EX-23.1 1900
4 EX-FILING FEES tm2319079d1_ex-filingfees.htm EX-FILING FEES 17253
5 GRAPHIC tm2319079d1_ex5-1img001.jpg GRAPHIC 3267
  Complete submission text file 0001104659-23-073328.txt   91088
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272805 | Film No.: 231029880
SIC: 2834 Pharmaceutical Preparations